Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception

•The most commonly prescribed contraceptives in publicly insured patients with SCD are combination pills and depot medroxyprogesterone acetate.•No significant differences were found in TE rates in patients with SCD prescribed combined hormonal vs POCs. [Display omitted] Patients with sickle cell dis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood advances 2023-10, Vol.7 (20), p.6140-6150
Hauptverfasser:	Bala, Natasha S., Stanek, Joseph R., Vesely, Sara K., Cronin, Robert M., Creary, Susan E., Roe, Andrea H., Xu, Wendy, O’Brien, Sarah H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anemia, Sickle Cell - complications Anemia, Sickle Cell - drug therapy Anemia, Sickle Cell - epidemiology Child Contraceptives, Oral, Hormonal - adverse effects Female Hormonal Contraception Humans Medicare Progestins - adverse effects Retrospective Studies Thromboembolism - epidemiology Thromboembolism - etiology Thrombosis and Hemostasis United States - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!